|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/basic-course-in-drug-regulatory-affairs/
课程评论：没有评论
课程名称：药品监管事务基础课程 概述：本课程旨在为学生提供药品监管事务领域的全面概述。药品开发和审批的监管环境复杂且高度规范，因此在制药行业工作的人员必须理解关键原则和要求。在课程中，学生将学习药品开发的监管框架，包括从临床前研究到临床试验的各个阶段，以及良好临床规范的重要性。 学生还将深入了解监管提交，包括新药申请（NDA）和简化新药申请（ANDA），并学习制药产品的监管战略的重要性。 除了监管提交，课程还将涵盖批准后的要求和生命周期管理，包括质量保证和良好生产规范（GMP）、药物警戒和药物安全、以及药品监管事务中的合规和检查。学生将对参与药品审批的各个监管机构有一定了解，例如食品药品监督管理局（FDA），以及它们遵循的指导方针和法规。 最后，课程将探讨全球监管事务及其协调，以及药品监管事务的未来趋势和挑战。课程结束时，学生将全面理解药品监管事务领域，并能够有效应对药品开发和审批的复杂监管环境。
This course is intended to provide students with a comprehensive overview of the drug regulatory affairs field. The regulatory environment for drug development and approval is complex and highly regulated, and it is essential for those working in the pharmaceutical industry to understand the key principles and requirements.Throughout the course, students will learn about the regulatory framework for drug development, including the various phases of the drug development process, from preclinical studies to clinical trials, and the importance of good clinical practice. They will also gain a thorough understanding of regulatory submissions, including the new drug application (NDA) and abbreviated new drug application (ANDA), as well as the importance of regulatory strategies for pharmaceutical products.In addition to regulatory submissions, the course will cover post-approval requirements and lifecycle management, including quality assurance and good manufacturing practices (GMP), pharmacovigilance and drug safety, and compliance and inspections in drug regulatory affairs. Students will also learn about the various regulatory agencies involved in drug approval, such as the Food and Drug Administration (FDA), and the guidelines and regulations they follow.Finally, the course will explore global regulatory affairs and harmonization and the future trends and challenges in drug regulatory affairs. By the end of the course, students will have gained a comprehensive understanding of the drug regulatory affairs field and will be well-equipped to navigate the complex regulatory environment of drug development and approval.
